Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Systemic Pharmacokinetics Following Intravitreal Injections of Ranibizumab, Bevacizumab or Aflibercept in Patients With Neovascular Age-related Macular Degeneration

NCT02118831 is registered in ClinicalTrials.gov with California Retina Consultants as lead sponsor.

NCT NCT02118831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02118831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Systemic Pharmacokinetics Following Intravitreal Injections of Ranibizumab, Bevacizumab or Aflibercept in Patients With Neovascular Age-related Macular Degeneration
Lead sponsor
California Retina Consultants
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2012
Completion date
April 30, 2014
Enrollment
56 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration, diabetic macular edema, retinal vein occlusion